An international controlled trial in multifactorial prevention of coronary heart disease (author transl)
Przeglad Lekarski 32(6): 495-502
1975
PMID: 1144816 Document Number: 460639
Document emailed within 1 workday
Related Documents
Steinbach, M.; Constantineanu, M.; Harnagea, P.; Theodorini, S.; Georgescu, M.; Mitu, S.; Tănăseanu, S.; Tănăsescu, C.; Teodorescu, S.; Voiculescu, M.; Voiosu, R.; Cucu, F.; Suciu, A.; Schioiu, L.; Ciobanu, F.; Chirulescu, Z.; Schiau, M.; Cherciu, M.; Stoica, V.; David, D.; Stănescu, C.; Stefănescu, S.; Ionescu, A. 1982: The Bucharest multifactorial prevention trial of coronary heart disease. General methodology and risk factor correction after five year follow-up (1971-1977) Medecine Interne 20(2): 117-136Cucu, F.; Purice, S.; Schioiu-Costache, L.; Damşa, T.; Suciu, A.; Cherciu, A.; Steinbach, M. 1991: Seasonal variations of serum cholesterol detected in the Bucharest Multifactorial Prevention Trial of Coronary Heart Disease. Ten years follow-up (1971-1982) Romanian Journal of Internal Medicine 29(1-2): 15-21
Baba, H.; Shinkai, A.; Azuma, Y. 1979: Controlled clinical trial of three 6 month regimens of chemotherapy for pulmonary tuberculosis. (Report 2)--Results at one year after completing chemotherapy--(author's transl) Kekkaku: 54(1): 29-36
Zhang, H.; Jiang, Y.; Nguyen, H.D.; Poo, D.Chiang.Choon.; Wang, W. 2017: The effect of a smartphone-based coronary heart disease prevention (SBCHDP) programme on awareness and knowledge of CHD, stress, and cardiac-related lifestyle behaviours among the working population in Singapore: a pilot randomised controlled trial Health and Quality of Life Outcomes 15(1): 49
Werkö, L. 1979: Prevention of heart attacks. A multifactorial preventive trial in Gothenburg, Sweden Annals of Clinical Research 11(2): 71-79
Zheng, H.; Guo, H.; Ye, J.-r.; Chen, L. 2012: Development and evaluation of individualized fluid therapy in the elderly patients with coronary heart disease undergoing gastrointestinal surgery: a randomized, controlled trial Zhonghua Wei Chang Wai Ke Za Zhi 15(6): 564-569
Ushakov, G.N.; Gasilin, V.S.; Konovalov, S.V.; Melent'ev, A.S.; Kruglov, V.A.; Rostokin, I.A.; Akhromeev, A.V. 1989: Effectiveness of primary multifactorial prevention of ischemic heart disease Sovetskoe Zdravookhranenie 1989(9): 34-37
Pokrovskaia, E.V. 2004: Final confirmation of inefficiency of antibiotics in secondary prevention of coronary heart disease. Results of PROVE IT (gatifloxacin trial) and ACES Kardiologiia 44(10): 82-83
Pavlova, L.I.; Chazova, L.V.; Kalinina, A.M.; Shchepkin, V.V. 1991: Diagnosis of myocardial infarct with fatal outcome within the framework of multifactorial prevention of ischemic heart disease in Moscow Kardiologiia 31(2): 59-61
1997: Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group Lancet 349(9049): 375-380
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Serruys, P.W.J.C.; de Feyter, P.; Macaya, C.; Kokott, N.; Puel, J.; Vrolix, M.; Branzi, A.; Bertolami, M.C.; Jackson, G.; Strauss, B.; Meier, B. 2002: Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial JAMA 287(24): 3215-3222
Leowattana, W.; Bhuripanyo, K.; Singhaviranon, L.; Akaniroj, S.; Mahanonda, N.; Samranthin, M.; Pokum, S. 2001: Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial Journal of the Medical Association of Thailand 84 Suppl. 3: S669-S675
Samuelsson, O.G.; Wilhelmsen, L.W.; Pennert, K.M.; Wedel, H.; Berglund, G.L. 1990: The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden Journal of Hypertension 8(6): 547-555
Kay, J.; Chow, W.Hing.; Chan, T.Mao.; Lo, S.Kai.; Kwok, O.Hing.; Yip, A.; Fan, K.; Lee, C.Hang.; Lam, W.Fai. 2003: Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289(5): 553-558
Chen, W-Hong.; Kaul, U.; Leung, S-Kin.; Lau, Y-Kong.; Tan, H-Cheem.; Leung, A.Wai-Suen.; Lee, M.Kang-Yin.; Li, S-Kin.; Ng, W.; Lee, P-Yin.; Lam, K-Fai.; Tse, H-Fat.; Lau, C-Pak. 2005: A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial Journal of Invasive Cardiology 17(10): 534-538
Jeuken, M. 1975: The animal in the environment of man(author's transl) Tijdschrift Voor Diergeneeskunde 100(13): 692-696
Tsutsui, J. 1976: Retinal hemorrhage (author's transl No Shinkei Geka. Neurological Surgery 4(9): 839-841
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Rywik, S.; Charzewska, J.; Napierala, M.; Bieganowska, K.; Wagrowska, H.; Szostak, W.B.; Michalski, E. 1977: The general discription of the population of the first pair of the Warsaw factories covered by the Polish trial on multifactorial prevention of I.H.D. Przeglad Lekarski 34(8): 615-620